Reports
The Royalty Rate Report 2009: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
The Definitive Industry Reference, this report is a “must read” for anyone involved in deal making who wants to get the maximum value from their next deal.
"The report sets out to give the reader a full insight into determining valuation and royalties and the huge impact that these terms can have on deals and their ultimate survival."
Dr Fintan Walton,
CEO of PharmaVentures
The content has been formulated by leveraging over 15 years of experience in assisting pharmaceutical and biotechnology companies worldwide in all aspects of deal making, and in response to valued feedback from our extensive market research. This report follows on from the publication of previous top selling reports on the topic of royalty rates.
- Clear guidance on the best methodologies to use when calculating Royalty Rates to assist with vital decision making
- Opinions and advice from leading industry deal makers on how to calculate Royalty Rates
- Contextual information – The report reviews the appropriate methodologies to use as part of the process to calculate Royalty Rates in-depth. It explores questions such as: “What do royalties mean in terms of value?” and “Where do royalties fit within the deal?”
- More case studies – PharmaVentures highlights the issues and pitfalls so that you can avoid them
Bookmarks
Bookmark PharmaDeals through one of these social networks.
